Daré Bioscience Inc.

NASDAQ: DARE · Real-Time Price · USD
2.02
-0.09 (-4.27%)
At close: Aug 19, 2025, 3:59 PM
2.06
1.73%
After-hours: Aug 19, 2025, 06:21 PM EDT

Daré Bioscience Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-4.05M -30.16M -30.95M -38.7M
Depreciation & Amortization
42.33K 38.36K 24.2K 26.41K
Stock-Based Compensation
2.2M 2.53M 2.16M 1.6M
Other Working Capital
7.02M -13.45M 10.77M 7.65M
Other Non-Cash Items
1.39M 78.32K -23.06K -51.85K
Deferred Income Tax
n/a n/a n/a -369.89K
Change in Working Capital
5.81M -11.34M 10.7M 8.73M
Operating Cash Flow
5.39M -38.86M -18.09M -28.76M
Capital Expenditures
-573.05K -629.43K -63.07K -14.52K
Cash Acquisitions
n/a n/a 925M 925M
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -925M -925M
Investing Cash Flow
-573.05K -629.43K -63.07K -14.52K
Debt Repayment
-17.56K 267.19K n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-2.19K 6.02M 124.6K 532.67K
Financial Cash Flow
433.83K 15.64M 1.34M 75.85M
Net Cash Flow
5.19M -23.86M -17M 47M
Free Cash Flow
4.82M -39.49M -18.15M -28.78M